<DOC>
	<DOC>NCT02720354</DOC>
	<brief_summary>[11C]-dimethyl-diphenyl ammonium ([11C]-DMDPA) - A Phase I, Open‑label, Safety and Tolerability, Radiation Dosimetry, Biodistribution, First‑in-Human Study of a Novel 11C‑labeled Tracer for Positron Emission Tomography Myocardial Perfusion Imaging</brief_summary>
	<brief_title>A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>body mass index (BMI) between 18.0 and 30.0 kg/m2 good health written informed consent smokers subject receiving medication a blood transfusion in the 4 weeks prior to screening positive alcohol blood test Subjects who suffer from claustrophobia Subjects who have had a clinically significant illness Subjects exposed to radiation within 12 months prior to screening</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>